In a significant move to bolster collaborations, the Pharmacy and Poisons Board (PPB) of Kenya and the United States Food and Drug Administration (US FDA) have signed a Statement of Commitment. Mark Abdoo, the Associate Director for Global Policy and Strategy at the US FDA, and Dr. Ahmed Mohamed, PPBโs Director of Health Products and Technologies, formalized the agreement on Thursday.
This event follows a confidentiality agreement signed between PPB and the US FDA in March 2024, aimed at fostering new opportunities for cooperative engagement in the pharmaceutical sector.
The US FDA delegation also visited the Ministry of Health, where they were received by Dr. Patrick Amoth, the Director General, representing Health Cabinet Secretary Susan Nakhumicha. Dr. Amoth emphasized the government’s Bottom-up Economic Transformation agenda, highlighting health as a key pillar of Universal Health Coverage.
